Stories
Slash Boxes
Comments

SoylentNews is people

posted by janrinok on Sunday April 15 2018, @06:48AM   Printer-friendly
from the enough-to-make-you-sick dept.

One-shot cures for diseases are not great for business—more specifically, they’re bad for longterm profits—Goldman Sachs analysts noted in an April 10 report for biotech clients, first reported by CNBC.

The investment banks’ report, titled “The Genome Revolution,” asks clients the touchy question: “Is curing patients a sustainable business model?” The answer may be “no,” according to follow-up information provided.

[...] The potential to deliver “one shot cures” is one of the most attractive aspects of gene therapy, genetically engineered cell therapy, and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies... While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.

[...] Ars reached out to Goldman Sachs, which confirmed the content of the report but declined to comment.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by Wootery on Monday April 16 2018, @02:21PM

    by Wootery (2341) on Monday April 16 2018, @02:21PM (#667633)

    If they don't want the $3bn, let them give it to me!

    That's a completely vacuous quip. I'm sure you understand as well as the rest of us that investors are looking for growth, not absolute worth.

    The greed involved in the Pharma business is legendary

    All companies tend to be greedy. The real issue is entrusting the whole affair to for-profit companies in the first place. I'm sure we could just as rightly accuse The Lego Group of being greedy; the difference isn't the greed, it's the life-or-death problem-domain.

    Starting Score:    1  point
    Karma-Bonus Modifier   +1  

    Total Score:   2